01 1Erregierre SpA
01 1N-4-Trifluromethyl Benzyl-4-Methoxybutyramide
01 1Italy
NDC Package Code : 49706-1945
Start Marketing Date : 2013-10-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
10
PharmaCompass offers a list of GET-73 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right GET-73 manufacturer or GET-73 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred GET-73 manufacturer or GET-73 supplier.
PharmaCompass also assists you with knowing the GET-73 API Price utilized in the formulation of products. GET-73 API Price is not always fixed or binding as the GET-73 Price is obtained through a variety of data sources. The GET-73 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A GET-73 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of GET-73, including repackagers and relabelers. The FDA regulates GET-73 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. GET-73 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A GET-73 supplier is an individual or a company that provides GET-73 active pharmaceutical ingredient (API) or GET-73 finished formulations upon request. The GET-73 suppliers may include GET-73 API manufacturers, exporters, distributors and traders.
click here to find a list of GET-73 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing GET-73 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for GET-73 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture GET-73 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain GET-73 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a GET-73 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of GET-73 suppliers with NDC on PharmaCompass.
